NO139049C - Analogifremgangsmaate for fremstilling av terapeutisk aktive triaziner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive triaziner

Info

Publication number
NO139049C
NO139049C NO741044A NO741044A NO139049C NO 139049 C NO139049 C NO 139049C NO 741044 A NO741044 A NO 741044A NO 741044 A NO741044 A NO 741044A NO 139049 C NO139049 C NO 139049C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogical procedure
triazines
active triazines
Prior art date
Application number
NO741044A
Other languages
English (en)
Norwegian (no)
Other versions
NO139049B (no
NO741044L (no
Inventor
Helmut Staehle
Herbert Koeppe
Werner Kummer
Wolfgang Hoefke
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO741044L publication Critical patent/NO741044L/no
Publication of NO139049B publication Critical patent/NO139049B/no
Publication of NO139049C publication Critical patent/NO139049C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO741044A 1973-03-23 1974-03-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive triaziner NO139049C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2314488A DE2314488C3 (de) 1973-03-23 1973-03-23 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel

Publications (3)

Publication Number Publication Date
NO741044L NO741044L (no) 1974-09-24
NO139049B NO139049B (no) 1978-09-18
NO139049C true NO139049C (no) 1979-01-03

Family

ID=5875651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO741044A NO139049C (no) 1973-03-23 1974-03-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive triaziner

Country Status (26)

Country Link
US (1) US3887552A (US20090163788A1-20090625-C00002.png)
JP (1) JPS5821634B2 (US20090163788A1-20090625-C00002.png)
AT (1) AT331256B (US20090163788A1-20090625-C00002.png)
BE (1) BE812736A (US20090163788A1-20090625-C00002.png)
BG (2) BG23750A3 (US20090163788A1-20090625-C00002.png)
CA (1) CA1017339A (US20090163788A1-20090625-C00002.png)
CH (2) CH588492A5 (US20090163788A1-20090625-C00002.png)
CS (1) CS191229B2 (US20090163788A1-20090625-C00002.png)
DD (1) DD112266A5 (US20090163788A1-20090625-C00002.png)
DE (1) DE2314488C3 (US20090163788A1-20090625-C00002.png)
DK (1) DK139519C (US20090163788A1-20090625-C00002.png)
ES (2) ES424346A1 (US20090163788A1-20090625-C00002.png)
FI (1) FI55664C (US20090163788A1-20090625-C00002.png)
FR (1) FR2222100B1 (US20090163788A1-20090625-C00002.png)
GB (1) GB1455356A (US20090163788A1-20090625-C00002.png)
HU (1) HU171082B (US20090163788A1-20090625-C00002.png)
IE (1) IE39965B1 (US20090163788A1-20090625-C00002.png)
IL (1) IL44470A (US20090163788A1-20090625-C00002.png)
NL (1) NL179479C (US20090163788A1-20090625-C00002.png)
NO (1) NO139049C (US20090163788A1-20090625-C00002.png)
PL (2) PL92111B1 (US20090163788A1-20090625-C00002.png)
RO (2) RO63042A (US20090163788A1-20090625-C00002.png)
SE (1) SE419087B (US20090163788A1-20090625-C00002.png)
SU (2) SU496734A3 (US20090163788A1-20090625-C00002.png)
YU (2) YU36959B (US20090163788A1-20090625-C00002.png)
ZA (1) ZA741864B (US20090163788A1-20090625-C00002.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1428269A (en) * 1973-11-07 1976-03-17 Ici Ltd Pyrimidino-triazine compounds and their use as pesticides
US4289778A (en) * 1977-12-27 1981-09-15 Eli Lilly And Company 2-(Substituted imino)-N-(3-substituted phenyl)-3-thiazolidinecarbothioamides
JPS6050207U (ja) * 1983-09-09 1985-04-09 ビ−・エス・コンクリ−ト株式会社 桁下の吊り足場
JPS61246273A (ja) * 1985-04-25 1986-11-01 Dainippon Ink & Chem Inc 顔料ベ−スト

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques

Also Published As

Publication number Publication date
BG23006A3 (US20090163788A1-20090625-C00002.png) 1977-05-20
NL179479B (nl) 1986-04-16
YU79074A (en) 1982-06-18
SU496734A3 (ru) 1975-12-25
PL92111B1 (US20090163788A1-20090625-C00002.png) 1977-03-31
DK139519C (da) 1979-08-20
NL7403893A (US20090163788A1-20090625-C00002.png) 1974-09-25
DE2314488A1 (de) 1974-10-03
IL44470A0 (en) 1974-06-30
ATA193674A (de) 1975-11-15
GB1455356A (en) 1976-11-10
SE419087B (sv) 1981-07-13
JPS49135991A (US20090163788A1-20090625-C00002.png) 1974-12-27
FR2222100A1 (US20090163788A1-20090625-C00002.png) 1974-10-18
CS191229B2 (en) 1979-06-29
AT331256B (de) 1976-08-10
DK139519B (da) 1979-03-05
CH588492A5 (US20090163788A1-20090625-C00002.png) 1977-06-15
ES424345A1 (es) 1976-06-01
BG23750A3 (en) 1977-10-12
DE2314488C3 (de) 1979-01-04
FI55664C (fi) 1979-09-10
ZA741864B (en) 1975-11-26
SU519135A3 (ru) 1976-06-25
DE2314488B2 (de) 1978-05-11
IE39965B1 (en) 1979-02-14
FI55664B (fi) 1979-05-31
RO68650A (ro) 1980-04-15
YU36961B (en) 1984-08-31
YU36959B (en) 1984-08-31
US3887552A (en) 1975-06-03
NO139049B (no) 1978-09-18
IE39965L (en) 1974-09-23
AU6703774A (en) 1975-09-25
BE812736A (fr) 1974-09-23
PL88663B1 (US20090163788A1-20090625-C00002.png) 1976-09-30
CH584714A5 (US20090163788A1-20090625-C00002.png) 1977-02-15
YU176380A (en) 1982-06-18
ES424346A1 (es) 1976-06-01
CA1017339A (en) 1977-09-13
HU171082B (hu) 1977-11-28
IL44470A (en) 1977-08-31
FR2222100B1 (US20090163788A1-20090625-C00002.png) 1977-11-10
JPS5821634B2 (ja) 1983-05-02
NL179479C (nl) 1986-09-16
RO63042A (fr) 1978-05-15
DD112266A5 (US20090163788A1-20090625-C00002.png) 1975-04-05
NO741044L (no) 1974-09-24

Similar Documents

Publication Publication Date Title
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO140301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO136837C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO140821C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO139386C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive imidazopyridiner
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO136574C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater.
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO139049C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triaziner
NO138375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cefalosporinderivater